SEC Info - Bioforce Nanosciences Holdings, Inc. - ‘10-K’ for 12/31/20

SEC Info℠

Home

Help

Please Sign In

Bioforce Nanosciences Holdings, Inc. – ‘10-K’ for 12/31/20

On: Tuesday, 2/16/21, at 9:08am ET · For: 12/31/20 · Accession #: 1091818-21-16 · File #: 0-51074

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  Bioforce Nanosciences Holdin… Inc 10-K       12/31/20   32:1.3M                                   Yes International/FA

Annual Report — Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Year End Report Dec. 31, 2020                       HTML    176K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     13K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     13K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     10K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     10K 
12: R1          Document and Entity Information                     HTML     49K 
13: R2          Consolidated Balance Sheets                         HTML     62K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     20K 
15: R4          Consolidated Statements of Operations               HTML     44K 
16: R5          Consolidated Statements of Cash Flows               HTML     66K 
17: R6          Statements of Changes in Stockholders' (Deficit)    HTML     43K 
                Equity                                                           
18: R7          Organization & Description of Business              HTML     15K 
19: R8          Summary of Significant Accounting Policies          HTML     18K 
20: R9          Recently Issued Accounting Standards                HTML     14K 
21: R10         Going Concern                                       HTML     14K 
22: R11         Related Party Transactions                          HTML     15K 
23: R12         Stock                                               HTML     16K 
24: R13         Risks and Uncertainties                             HTML     15K 
25: R14         Summary of Significant Accounting Policies          HTML     37K 
                (Policies)                                                       
26: R15         Organization & Description of Business (Details)    HTML     15K 
27: R16         Related Party Transactions (Details)                HTML     16K 
28: R17         Stock (Details)                                     HTML     47K 
29: R18         Risks and Uncertainties (Details)                   HTML     21K 
31: XML         IDEA XML File -- Filing Summary                      XML     46K 
30: EXCEL       IDEA Workbook of Financial Reports                  XLSX     25K 
 6: EX-101.INS  XBRL Instance -- bfnh-20201231                       XML    167K 
 8: EX-101.CAL  XBRL Calculations -- bfnh-20201231_cal               XML     71K 
 9: EX-101.DEF  XBRL Definitions -- bfnh-20201231_def                XML     95K 
10: EX-101.LAB  XBRL Labels -- bfnh-20201231_lab                     XML    306K 
11: EX-101.PRE  XBRL Presentations -- bfnh-20201231_pre              XML    223K 
 7: EX-101.SCH  XBRL Schema -- bfnh-20201231                         XSD     54K 
32: ZIP         XBRL Zipped Folder -- 0001091818-21-000016-xbrl      Zip     32K

Filing Submission 0001091818-21-000016 – SGML Text

Original SGML Text submitted by:	Yes International/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 1.3M ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20210216-100913	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20210216-090907	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20210216-090811	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001091818-21-000016
<TYPE>				10-K
<PUBLIC-DOCUMENT-COUNT>		37
<PERIOD>			20201231
<FILING-DATE>			20210216
<DATE-OF-FILING-DATE-CHANGE>	20210216

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		BIOFORCE NANOSCIENCES HOLDINGS, INC.
<CIK>				0001310488
<ASSIGNED-SIC>			3826
<IRS-NUMBER>			852138858  ⇒ 85-2138858
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			10-K
<ACT>				34
<FILE-NUMBER>			000-51074
<FILM-NUMBER>			21633148
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			2020 GENERAL BOOTH BLVD
<STREET2>			SUITE 230
<CITY>				VIRGINIA BEACH
<STATE>				VA
<ZIP>				23454
<PHONE>				757-306-6090
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			2020 GENERAL BOOTH BLVD
<STREET2>			SUITE 230
<CITY>				VIRGINIA BEACH
<STATE>				VA
<ZIP>				23454
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		SILVER RIVER VENTURES, INC.
<DATE-CHANGED>			20041202
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		10-K
<SEQUENCE>	1
<FILENAME>	bfnh01222021form10kdec2020.htm
<DESCRIPTION>	YEAR END REPORT DEC. 31, 2020
<TEXT>
<HTML>
       Show <HTML>: 1,733 lines (widest: 2,198 characters) - 208K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-31.1
<SEQUENCE>	2
<FILENAME>	ex311.htm
<DESCRIPTION>	CERTIFICATION
<TEXT>
<html>
       Show <HTML>: 25 lines (widest: 467 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-31.2
<SEQUENCE>	3
<FILENAME>	ex312.htm
<DESCRIPTION>	CERTIFICATION
<TEXT>
<html>
       Show <HTML>: 27 lines (widest: 467 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-32.1
<SEQUENCE>	4
<FILENAME>	ex321.htm
<DESCRIPTION>	CERTIFICATION
<TEXT>
<html>
       Show <HTML>: 23 lines (widest: 468 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-32.2
<SEQUENCE>	5
<FILENAME>	ex322.htm
<DESCRIPTION>	CERTIFICATION
<TEXT>
<html>
       Show <HTML>: 21 lines (widest: 509 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.INS
<SEQUENCE>	6
<FILENAME>	bfnh-20201231.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
       Show <XBRL>: 616 lines (widest: 6,570 characters) - 71K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	7
<FILENAME>	bfnh-20201231.xsd
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
       Show <XBRL>: 188 lines (widest: 808 characters) - 18K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.CAL
<SEQUENCE>	8
<FILENAME>	bfnh-20201231_cal.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 136 lines (widest: 316 characters) - 26K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.DEF
<SEQUENCE>	9
<FILENAME>	bfnh-20201231_def.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 185 lines (widest: 359 characters) - 36K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	10
<FILENAME>	bfnh-20201231_lab.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 578 lines (widest: 341 characters) - 118K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	11
<FILENAME>	bfnh-20201231_pre.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 445 lines (widest: 341 characters) - 90K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	12  ⇐ Not a Document/Exhibit
<FILENAME>	a0101450current001.jpg
<TEXT>
       Show <TEXT>: 474 lines (Unix-to-Unix encoding) - 29K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	13  ⇐ Not a Document/Exhibit
<FILENAME>	a0101450current002.jpg
<TEXT>
       Show <TEXT>: 318 lines (Unix-to-Unix encoding) - 20K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	14  ⇐ Not a Document/Exhibit
<FILENAME>	a0101450current003.jpg
<TEXT>
       Show <TEXT>: 4,459 lines (Unix-to-Unix encoding) - 270K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	15  ⇐ Document/Exhibit 12
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 826 lines (widest: 562 characters) - 39K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	16  ⇐ Document/Exhibit 13
<FILENAME>	R2.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 668 lines (widest: 3,099 characters) - 52K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	17  ⇐ Document/Exhibit 14
<FILENAME>	R3.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 202 lines (widest: 701 characters) - 11K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	18  ⇐ Document/Exhibit 15
<FILENAME>	R4.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 420 lines (widest: 6,806 characters) - 35K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	19  ⇐ Document/Exhibit 16
<FILENAME>	R5.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 891 lines (widest: 6,806 characters) - 54K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	20  ⇐ Document/Exhibit 17
<FILENAME>	R6.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 537 lines (widest: 6,806 characters) - 33K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	21  ⇐ Document/Exhibit 18
<FILENAME>	R7.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 92 lines (widest: 924 characters) - 7K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	22  ⇐ Document/Exhibit 19
<FILENAME>	R8.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 120 lines (widest: 759 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	23  ⇐ Document/Exhibit 20
<FILENAME>	R9.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 92 lines (widest: 589 characters) - 6K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	24  ⇐ Document/Exhibit 21
<FILENAME>	R10.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 94 lines (widest: 1,019 characters) - 7K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	25  ⇐ Document/Exhibit 22
<FILENAME>	R11.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 94 lines (widest: 1,463 characters) - 7K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	26  ⇐ Document/Exhibit 23
<FILENAME>	R12.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 103 lines (widest: 933 characters) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	27  ⇐ Document/Exhibit 24
<FILENAME>	R13.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 98 lines (widest: 645 characters) - 7K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	28  ⇐ Document/Exhibit 25
<FILENAME>	R14.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 310 lines (widest: 2,941 characters) - 28K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	29  ⇐ Document/Exhibit 26
<FILENAME>	R15.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 127 lines (widest: 711 characters) - 7K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	30  ⇐ Document/Exhibit 27
<FILENAME>	R16.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 161 lines (widest: 413 characters) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	31  ⇐ Document/Exhibit 28
<FILENAME>	R17.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 717 lines (widest: 1,314 characters) - 36K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	32  ⇐ Document/Exhibit 29
<FILENAME>	R18.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 194 lines (widest: 3,961 characters) - 13K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	33  ⇐ Document/Exhibit 30
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 570 lines (Unix-to-Unix encoding) - 35K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	34  ⇐ Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	35  ⇐ Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	36  ⇐ Document/Exhibit 31
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 243 lines (widest: 105 characters) - 11K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	38  ⇒ 37  ⇐ Document/Exhibit 32
<FILENAME>	0001091818-21-000016-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 712 lines (Unix-to-Unix encoding) - 43K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001091818-21-000016 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Bioforce Nanosciences Holdings, Inc. – ‘10-K’ for 12/31/20

On: Tuesday, 2/16/21, at 9:08am ET · For: 12/31/20 · Accession #: 1091818-21-16 · File #: 0-51074

Annual Report — Form 10-KFiling Table of Contents

Annual Report — Form 10-K
Filing Table of Contents